Symbols / RPID Stock $2.46 +4.24% Rapid Micro Biosystems, Inc.

Healthcare • Medical Devices • United States • NCM
RPID (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Robert G. Spignesi Jr.
Exch · Country NCM · United States
Market Cap 112.59M
Enterprise Value 96.98M
Income -47.12M
Sales 33.59M
FCF (ttm) -15.77M
Book/sh 0.75
Cash/sh 0.85
Employees 171
Insider 10d —
IPO Jul 15, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -2.99
PEG —
P/S 3.35
P/B 3.29
P/C —
EV/EBITDA -2.17
EV/Sales 2.89
Quick Ratio 2.27
Current Ratio 3.31
Debt/Eq 71.90
LT Debt/Eq —
EPS (ttm) -1.00
EPS next Y -0.82
EPS Growth —
Revenue Growth 37.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-08
Earnings (prior) 2026-03-12
ROA -34.24%
ROE -86.82%
ROIC —
Gross Margin 3.12%
Oper. Margin -108.23%
Profit Margin -140.30%
Shs Outstand 41.27M
Shs Float 22.38M
Insider Own 9.94%
Instit Own 57.28%
Short Float 2.04%
Short Ratio 2.29
Short Interest 543.87K
52W High 4.94
vs 52W High -50.20%
52W Low 2.01
vs 52W Low 22.39%
Beta 1.60
Impl. Vol. —
Rel Volume 0.67
Avg Volume 215.85K
Volume 145.59K
Target (mean) $8.00
Tgt Median $8.00
Tgt Low $8.00
Tgt High $8.00
# Analysts 3
Recom Strong_buy
Prev Close $2.36
Price $2.46
Change 4.24%
About

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.00
Mean price target
2. Current target
$2.46
Latest analyst target
3. DCF / Fair value
$-6.88
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.46
Low
$8.00
High
$8.00
Mean
$8.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-07-28 init Lake Street — → Buy $8
2025-02-12 init Keybanc — → Overweight $8
2023-03-07 reit Morgan Stanley — → Equal-Weight $3
2022-08-16 down JP Morgan Overweight → Neutral —
2022-05-11 main Morgan Stanley — → Equal-Weight $8
2022-03-07 main Morgan Stanley — → Equal-Weight $10
2022-02-15 main Morgan Stanley — → Equal-Weight $11
2021-11-15 main Morgan Stanley — → Equal-Weight $24
2021-08-09 init Cowen & Co. — → Outperform —
2021-08-09 init Morgan Stanley — → Equal-Weight $26
2021-08-09 init Stifel — → Buy $28
2021-08-09 init JP Morgan — → Overweight $30
News
RSS: Latest RPID news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-11 WIRTJES SEAN M. CPA Chief Financial Officer — 7,480 $4.32 $32,299
2026-03-11 WILSON JOHN J. ADDINGTON Chief Operating Officer — 9,603 $4.32 $41,467
2026-03-10 SPIGNESI ROBERT G JR Chief Executive Officer — 17,922 $4.11 $73,686
2026-02-27 RICCIARDI NATALE S Director — 842 $0.75 $632
2026-02-20 WIRTJES SEAN M. CPA Chief Financial Officer — 17,254 $3.92 $67,687
2026-02-20 WILSON JOHN J. ADDINGTON Chief Operating Officer — 5,403 $3.92 $21,196
2026-02-19 SPIGNESI ROBERT G JR Chief Executive Officer — 38,327 $3.89 $148,912
2026-02-11 WIRTJES SEAN M. CPA Chief Financial Officer — 97,000 $0.00 $0
2026-02-11 WILSON JOHN J. ADDINGTON Chief Operating Officer — 74,000 $0.00 $0
2026-02-11 SPIGNESI ROBERT G JR Chief Executive Officer — 264,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
33.59
+19.74%
28.05
+24.57%
22.52
+31.44%
17.13
Operating Revenue
33.59
+19.74%
28.05
+24.57%
22.52
+31.44%
17.13
Cost Of Revenue
32.54
+15.55%
28.16
+0.56%
28.00
+9.08%
25.67
Reconciled Cost Of Revenue
32.54
+15.55%
28.16
+0.56%
28.00
+9.08%
25.67
Gross Profit
1.05
+1060.55%
-0.11
+98.01%
-5.49
+35.77%
-8.54
Operating Expense
48.44
-2.75%
49.81
-2.48%
51.08
-6.59%
54.68
Research And Development
13.60
-6.81%
14.60
+13.86%
12.82
-0.36%
12.87
Selling General And Administration
34.84
-1.07%
35.21
-7.96%
38.26
-8.50%
41.81
Selling And Marketing Expense
12.08
-8.93%
13.27
-0.42%
13.32
-11.15%
14.99
General And Administrative Expense
22.75
+3.68%
21.95
-11.99%
24.94
-7.02%
26.82
Other Gand A
22.75
+3.68%
21.95
-11.99%
24.94
-7.02%
26.82
Total Expenses
80.98
+3.86%
77.97
-1.41%
79.08
-1.58%
80.35
Operating Income
-47.39
+5.06%
-49.92
+11.75%
-56.56
+10.53%
-63.22
Total Operating Income As Reported
-47.39
+5.06%
-49.92
+11.75%
-56.56
+10.53%
-63.22
EBITDA
-42.74
+8.20%
-46.56
+12.91%
-53.46
+11.47%
-60.38
Normalized EBITDA
-42.74
+8.20%
-46.56
+12.91%
-53.46
+11.47%
-60.38
Reconciled Depreciation
3.25
-3.27%
3.36
+8.28%
3.10
+9.45%
2.84
EBIT
-45.99
+7.86%
-49.92
+11.75%
-56.56
+10.53%
-63.22
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Pretax Income
-47.08
-0.46%
-46.87
+10.62%
-52.44
+14.57%
-61.38
Net Non Operating Interest Income Expense
0.42
-86.76%
3.16
-24.85%
4.21
+136.78%
1.78
Interest Expense Non Operating
1.09
—
—
—
Net Interest Income
0.42
-86.76%
3.16
-24.85%
4.21
+136.78%
1.78
Interest Expense
1.09
—
—
—
Interest Income Non Operating
1.51
-52.31%
3.16
-24.85%
4.21
+136.78%
1.78
Interest Income
1.51
-52.31%
3.16
-24.85%
4.21
+136.78%
1.78
Other Income Expense
-0.11
+1.79%
-0.11
-34.94%
-0.08
-240.68%
0.06
Other Non Operating Income Expenses
-0.11
+1.79%
-0.11
-34.94%
-0.08
-240.68%
0.06
Gain On Sale Of Security
—
—
—
—
Tax Provision
0.04
+81.82%
0.02
-29.03%
0.03
+105.38%
-0.58
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+2000.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Net Income From Continuing Operation Net Minority Interest
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Net Income From Continuing And Discontinued Operation
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Net Income Continuous Operations
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Normalized Income
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Net Income Common Stockholders
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
—
-1.08
+11.48%
-1.22
+14.69%
-1.43
Basic EPS
—
-1.08
+11.48%
-1.22
+14.69%
-1.43
Basic Average Shares
—
43.58
+1.28%
43.02
+1.34%
42.45
Diluted Average Shares
—
43.58
+1.28%
43.02
+1.34%
42.45
Diluted NI Availto Com Stockholders
-47.12
-0.50%
-46.89
+10.63%
-52.47
+13.71%
-60.81
Preferred Stock Dividends
—
—
—
—
Total Other Finance Cost
—
—
—
-1.78
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
74.85
-23.75%
98.17
-31.57%
143.45
-24.76%
190.65
Current Assets
61.17
-24.41%
80.92
-32.80%
120.42
-13.11%
138.58
Cash Cash Equivalents And Short Term Investments
38.30
-24.51%
50.73
-44.89%
92.05
-15.27%
108.65
Cash And Cash Equivalents
20.03
+18.44%
16.91
-30.36%
24.29
-10.27%
27.06
Other Short Term Investments
18.27
-45.99%
33.82
-50.09%
67.77
-16.93%
81.58
Receivables
3.28
-56.44%
7.53
+34.78%
5.58
+1.86%
5.48
Accounts Receivable
3.13
-58.32%
7.52
+35.92%
5.53
+3.04%
5.37
Other Receivables
0.14
+2300.00%
0.01
-88.24%
0.05
-54.46%
0.11
Inventory
17.59
-12.91%
20.20
+1.20%
19.96
-5.79%
21.19
Raw Materials
11.83
+12.03%
10.56
-17.97%
12.87
-14.26%
15.01
Work In Process
0.88
+137.63%
0.37
+148.00%
0.15
-90.62%
1.60
Finished Goods
4.88
-47.36%
9.27
+33.58%
6.94
+51.68%
4.57
Prepaid Assets
1.15
-29.07%
1.62
-27.84%
2.24
-12.29%
2.56
Other Current Assets
0.85
+1.30%
0.84
+46.10%
0.58
-18.16%
0.70
Total Non Current Assets
13.68
-20.68%
17.25
-25.11%
23.04
-55.76%
52.07
Net PPE
13.08
-20.02%
16.36
-14.24%
19.07
-8.66%
20.88
Gross PPE
32.38
-1.52%
32.88
-1.51%
33.38
+2.14%
32.68
Accumulated Depreciation
-19.30
-16.80%
-16.52
-15.45%
-14.31
-21.25%
-11.80
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.59
+4.35%
2.48
-2.51%
2.55
+13.79%
2.24
Construction In Progress
0.87
-45.29%
1.59
-30.45%
2.29
+33.88%
1.71
Other Properties
19.46
-0.79%
19.62
-1.85%
19.99
-2.35%
20.47
Leases
9.45
+2.93%
9.18
+7.33%
8.55
+3.52%
8.26
Investments And Advances
—
0.00
-100.00%
2.91
-90.23%
29.79
Other Non Current Assets
0.60
-32.70%
0.90
-14.99%
1.05
-24.88%
1.40
Total Liabilities Net Minority Interest
41.65
+82.52%
22.82
-10.39%
25.46
-3.84%
26.48
Current Liabilities
18.49
+5.25%
17.57
-7.48%
18.99
-0.34%
19.05
Payables And Accrued Expenses
7.63
+48.62%
5.14
-25.90%
6.93
-29.57%
9.84
Payables
4.41
+59.13%
2.77
+24.49%
2.23
-61.35%
5.76
Accounts Payable
4.14
+63.27%
2.54
+28.48%
1.97
-63.65%
5.43
Current Accrued Expenses
3.23
+36.31%
2.37
-49.72%
4.71
+15.23%
4.08
Pensionand Other Post Retirement Benefit Plans Current
4.80
+7.44%
4.46
-7.15%
4.81
+49.46%
3.22
Total Tax Payable
0.27
+14.47%
0.23
-6.75%
0.25
-23.40%
0.33
Current Debt And Capital Lease Obligation
1.30
+6.92%
1.21
+7.24%
1.13
+47.78%
0.77
Current Capital Lease Obligation
1.30
+6.92%
1.21
+7.24%
1.13
+47.78%
0.77
Current Deferred Liabilities
4.73
-28.26%
6.60
+10.46%
5.97
+26.94%
4.71
Current Deferred Revenue
4.73
-28.26%
6.60
+10.46%
5.97
+26.94%
4.71
Other Current Liabilities
0.03
-82.89%
0.15
+7.80%
0.14
-72.88%
0.52
Total Non Current Liabilities Net Minority Interest
23.16
+340.96%
5.25
-18.91%
6.48
-12.84%
7.43
Long Term Debt And Capital Lease Obligation
22.58
+355.71%
4.95
-20.28%
6.21
-13.72%
7.20
Long Term Debt
18.90
—
—
—
Long Term Capital Lease Obligation
3.67
-25.84%
4.95
-20.28%
6.21
-13.72%
7.20
Non Current Deferred Liabilities
—
—
—
0.00
Other Non Current Liabilities
0.40
+33.22%
0.30
+13.31%
0.26
+14.85%
0.23
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
33.21
-55.93%
75.35
-36.14%
117.99
-28.13%
164.17
Common Stock Equity
33.21
-55.93%
75.35
-36.14%
117.99
-28.13%
164.17
Capital Stock
0.45
+3.49%
0.43
+1.42%
0.42
+0.71%
0.42
Common Stock
0.45
+3.49%
0.43
+1.42%
0.42
+0.71%
0.42
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
44.47
+3.33%
43.04
+1.48%
42.41
+0.75%
42.09
Ordinary Shares Number
44.47
+3.33%
43.04
+1.48%
42.41
+0.75%
42.09
Additional Paid In Capital
555.15
+0.91%
550.16
+0.75%
546.05
+0.98%
540.77
Retained Earnings
-522.40
-9.91%
-475.27
-10.95%
-428.38
-13.96%
-375.92
Gains Losses Not Affecting Retained Earnings
0.01
-71.79%
0.04
+138.61%
-0.10
+90.89%
-1.11
Other Equity Adjustments
0.01
-71.79%
0.04
+138.61%
-0.10
—
Total Equity Gross Minority Interest
33.21
-55.93%
75.35
-36.14%
117.99
-28.13%
164.17
Total Capitalization
52.11
-30.85%
75.35
-36.14%
117.99
-28.13%
164.17
Working Capital
42.68
-32.63%
63.35
-37.54%
101.43
-15.14%
119.53
Invested Capital
52.11
-30.85%
75.35
-36.14%
117.99
-28.13%
164.17
Total Debt
23.87
+287.06%
6.17
-16.04%
7.35
-7.81%
7.97
Capital Lease Obligations
4.97
-19.39%
6.17
-16.04%
7.35
-7.81%
7.97
Net Tangible Assets
33.21
-55.93%
75.35
-36.14%
117.99
-28.13%
164.17
Tangible Book Value
33.21
-55.93%
75.35
-36.14%
117.99
-28.13%
164.17
Derivative Product Liabilities
0.19
—
—
—
Interest Payable
—
—
—
—
Investmentin Financial Assets
—
—
2.91
-90.23%
29.79
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-44.15
+2.06%
-45.08
+23.00%
-58.55
-6.52%
-54.96
Cash Flow From Continuing Operating Activities
-44.15
+2.06%
-45.08
+23.00%
-58.55
-6.52%
-54.96
Net Income From Continuing Operations
-46.89
+10.63%
-52.47
+13.71%
-60.81
+17.30%
-73.52
Depreciation Amortization Depletion
3.36
+8.28%
3.10
+9.45%
2.84
+85.55%
1.53
Depreciation And Amortization
3.36
+8.28%
3.10
+9.45%
2.84
+85.55%
1.53
Other Non Cash Items
1.20
-2.99%
1.24
+19.40%
1.04
+156.44%
0.40
Stock Based Compensation
3.87
-18.44%
4.75
+18.19%
4.02
+118.07%
1.84
Provisionand Write Offof Assets
0.10
+179.41%
0.03
-89.57%
0.33
+443.33%
0.06
Operating Gains Losses
—
—
0.03
-99.88%
22.73
Gain Loss On Investment Securities
—
—
—
19.64
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.03
+255.56%
-0.02
Change In Working Capital
-4.77
-959.64%
0.56
+110.42%
-5.33
+33.42%
-8.00
Change In Receivables
-1.99
-1119.02%
-0.16
+55.22%
-0.36
-2041.18%
-0.02
Changes In Account Receivables
-1.99
-1119.02%
-0.16
+55.22%
-0.36
-2041.18%
-0.02
Change In Inventory
-0.34
-128.08%
1.19
+120.42%
-5.84
+13.64%
-6.77
Change In Prepaid Assets
0.40
+48.16%
0.27
-52.94%
0.58
+152.31%
-1.10
Change In Payables And Accrued Expense
-3.33
-64.67%
-2.02
-58.39%
-1.28
-171.65%
1.78
Change In Accrued Expense
-3.89
-371.27%
1.43
+151.96%
-2.76
-219.74%
2.31
Change In Payable
0.56
+116.27%
-3.46
-332.82%
1.48
+383.21%
-0.52
Change In Account Payable
0.56
+116.27%
-3.46
-332.82%
1.48
+383.21%
-0.52
Change In Other Working Capital
0.63
-50.67%
1.27
-9.42%
1.40
+238.71%
-1.01
Change In Other Current Assets
-0.15
-3100.00%
0.01
-97.21%
0.18
+121.03%
-0.85
Change In Other Current Liabilities
—
—
0.00
+100.00%
-0.03
Investing Cash Flow
36.66
-13.04%
42.15
+145.10%
-93.47
-603.36%
-13.29
Cash Flow From Continuing Investing Activities
36.66
-13.04%
42.15
+145.10%
-93.47
-603.36%
-13.29
Net PPE Purchase And Sale
-1.36
+26.02%
-1.84
+72.63%
-6.74
-110.82%
-3.20
Purchase Of PPE
-1.36
+26.02%
-1.84
+72.63%
-6.74
-109.51%
-3.22
Sale Of PPE
—
—
0.00
-100.00%
0.02
Capital Expenditure
-1.36
+26.02%
-1.84
+72.63%
-6.74
-109.51%
-3.22
Net Investment Purchase And Sale
38.02
-13.58%
44.00
+150.73%
-86.73
-759.38%
-10.09
Purchase Of Investment
-35.03
+43.94%
-62.49
+65.13%
-179.23
-614.29%
-25.09
Sale Of Investment
73.06
-31.40%
106.49
+15.12%
92.50
+516.67%
15.00
Financing Cash Flow
0.20
+36.24%
0.15
-78.50%
0.69
-99.68%
216.75
Cash Flow From Continuing Financing Activities
0.20
+36.24%
0.15
-78.50%
0.69
-99.68%
216.75
Net Issuance Payments Of Debt
-0.04
+5.41%
-0.04
-12.12%
-0.03
+99.87%
-26.17
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
-0.04
+5.41%
-0.04
-12.12%
-0.03
+99.87%
-26.17
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
-0.04
+5.41%
-0.04
-12.12%
-0.03
+99.87%
-26.17
Net Long Term Debt Issuance
-0.04
+5.41%
-0.04
-12.12%
-0.03
+99.87%
-26.17
Net Common Stock Issuance
—
—
0.00
-100.00%
164.11
Proceeds From Stock Option Exercised
0.24
+27.96%
0.19
-74.38%
0.73
-21.60%
0.93
Net Other Financing Charges
—
—
—
-1.87
Changes In Cash
-7.29
-162.43%
-2.78
+98.16%
-151.32
-201.91%
148.49
Beginning Cash Position
24.57
-10.16%
27.35
-84.69%
178.67
+492.04%
30.18
End Cash Position
17.28
-29.68%
24.57
-10.16%
27.35
-84.69%
178.67
Free Cash Flow
-45.52
+3.00%
-46.93
+28.12%
-65.29
-12.21%
-58.18
Interest Paid Supplemental Data
0.04
+5.26%
0.04
-9.52%
0.04
-98.38%
2.59
Amortization Of Securities
-1.02
+55.38%
-2.29
-246.68%
-0.66
-21966.67%
-0.00
Common Stock Issuance
—
—
0.00
-100.00%
164.11
Issuance Of Capital Stock
—
—
0.00
-100.00%
243.86
Net Preferred Stock Issuance
—
—
0.00
-100.00%
79.74
Preferred Stock Issuance
—
—
0.00
-100.00%
79.74
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category